Given about 10% of melanoma patients harbor PP6c inactivating mutations, and dysregulated Hippo pathways are also associated with various diseases, especially with cancer, answering these questions will be very interesting and be the focus of future studies. This evidence concerns the gene PPP6C and cancer.